[Ofloxacin in the treatment of pulmonary changes caused by Mycobacterium avium and Mycobacterium xenopii].
Two cases of atypical mycobacterial infections are reported. The first caused by Mycobacterium avium in a patient with silicosis, the second by Mycobacterium xenopii in a subject with evidence of extensive post-tuberculosis pulmonary lesions. Both were treated with ofloxacin with good results.
Zwoliński
J
J
Katedry i Kliniki Chorób Płuc AM, Wrocławiu.
Gałazka
J
J
D006801:Humans; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D015269:Mycobacterium avium Complex / Q000187:drug effects* / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D009170:Nontuberculous Mycobacteria / Q000187:drug effects* / Q000302:isolation & purification; D015242:Ofloxacin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
D015242:Ofloxacin
Ofloksacyna w leczeniu zmian w płucach wywołanych przez Mycobacterium avium i Mycobacterium xenopii.